Biochemical Urinalysis Segment to Dominate Europe Urinalysis Market during 2020–2028      

According to a new market research study on “Europe Urinalysis Market to 2028 – COVID-19 Impact and Regional Analysis and Forecast by Product, Test Type, Application, End User” is expected to reach US$ 1,655.73 million by 2028 from 1,161.86 US$ million in 2021. The market is estimated to grow at a CAGR of 5.2% from 2021 to 2028. The report provides trends prevailing in the Europe urinalysis market along with the drivers and restraints pertaining to the market growth. Increasing geriatric population is resulting in rise in prevalence of age-related diseases, and this is the major factor driving the growth of the Europe urinalysis market. However, issues associated with product recalls strict regulatory requirements hinders the growth of Europe urinalysis market.  

Europe urinalysis market is segmented into product, test type, application, end user, and country. Based on product, the Europe urinalysis market is segmented into consumables and instruments. The consumables segment is expected to hold a larger market share in 2021. The Europe urinalysis market, based on test type, is segmented into pregnancy and fertility tests, biochemical urinalysis, and sediment urinalysis. The biochemical urinalysis segment would hold the largest share of the market in 2021. Based on application, the Europe urinalysis market is segmented into disease screening and pregnancy, and fertility. The disease screening segment would account for a larger market share in 2021. The Europe urinalysis market, by end user, is segmented into hospitals and clinics, diagnostic laboratories, home care settings, and research laboratories and institutes. The hospitals and clinics segment would hold the largest share of the market in 2021. Based on country, the Europe urinalysis market is segmented into France, Germany, Italy, Spain, the UK, and rest of Europe. Germany held the largest market share in 2021.

The urinalysis market witnessed a shortfall at the beginning of the COVID-19 crisis due to the lockdown restrictions announced by many European countries that caused disruptions in manufacturing and supply chain operations. Additionally, scheduled appointments and health checkups have been delayed in many clinics. Patients with the UTI suffered the inadequate availability of medical staff providing therapeutic services to treat their conditions. With the number of rising cases, the healthcare workers had to switch between their roles to meet the demand for healthcare staff to manage COVID-19. Hence, it caused a significant decrease in elective procedures due to a lack of healthcare resources. According to National Kidney Foundation, patients hospitalized with COVID-19 are at considerable risk of developing acute kidney injury (AKI), resulting in severe illnesses and death. The COVID-19 patients with blood or protein in their urine need to be continuously monitored as they are at a high risk of developing chronic kidney disease. However, with the implementation of proper precautionary measures and modification of protocols to reduce the chances of exposure to SARS-CoV-2 during patient visits, the hospitals have begun to continue their operations, and a resurgence in testing numbers evident due to relaxations in restrictions imposed on people’s movement.

Abbott; ACON Laboratories, Inc.; ARKRAY, Inc.; Beckman Coulter, Inc.; Bio-Rad Laboratories Inc.;        Cardinal Health Inc; F. Hoffmann-La Roche Ltd.; Quidel Corporation; Siemens Healthineers AG; and         Sysmex Corporation are among the leading companies in the Europe urinalysis market. The companies are focused on adopting organic growth strategies such as product launches and expansions to sustain their position in the dynamic market. For instance, ARKRAY, Inc. launched its "AUTION EYE AI-4510" on July 8, 2019. The urine sediment analyzer has compact design that enable its installation even in labs with limited space. It uses a flow-type image measurement method to capture images of formed elements inside urine samples, then extracts, analyzes, categorizes, and measures those formed element images, and then provides urine sediment test data. It supports a full series of urine testing processes, thereby contributed to the improved efficiency of testing operations.  
  
Contact Us
Phone: +16467917070
Email Id: sales@businessmarketinsights.com